Qureshi H, Sharafkhaneh A, Hanania NA (2014) Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis 5(5):212–227 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131503/
Brusselle G, Pavord ID, Landis S, Pascoe S, Lettis S, Morjaria N, Barnes N, Hilton E (2018) Blood eosinophil levels as a biomarker in COPD. Respir Med 138:21–31
Tashkin DP, Wechsler ME (2018) Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 13:335
Bafadhel M, Pavord ID, Russell RE (2017) Eosinophils in COPD: just another biomarker? Lancet Respir Med 5(9):747–759
Bafadhel M, Greening NJ, Harvey-Dunstan TC, Williams JE, Morgan MD, Brightling CE, Hussain SF, Pavord ID, Singh SJ, Steiner MC (2016) Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD. Chest. 150(2):320–328
Landis SH, Pimenta JM, Yang S, Compton C, Barnes N, Brusselle G (2019) Association between blood eosinophils and acute exacerbation of COPD risk in patients with COPD in primary care. Respiratory Medicine: X 1:100011
Feng X, Qian Z, Zhang B, Guo E, Wang L, Liu P, Wen X, Xu W, Jiang C, Li Y, Wu Z (2018) Number of cigarettes smoked per day, smoking index, and intracranial aneurysm rupture: a case–control study. Front Neurol 9:380
Milačić N, Milačić B, Dunjić O, Milojković M (2015) Validity of CAT and mMRC-dyspnea score in evaluation of COPD severity. Acta medica Medianae 54(1):66–70
Hastie AT, Martinez FJ, Curtis JL, Doerschuk CM, Hansel NN, Christenson S, Putcha N, Ortega VE, Li X, Barr RG, Carretta EE (2017) Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. Lancet Respir Med 5(12):956–967
Singh D, Roche N, Halpin D, Agusti A, Wedzicha JA, Martinez FJ (2016) Current controversies in the pharmacological treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 194(5):541–549
Kolsum U, Donaldson GC, Singh R, Barker BL, Gupta V, George L, Webb AJ, Thurston S, Brookes AJ, McHugh TD, Wedzicha JA (2017) Blood and sputum eosinophils in COPD; relationship with bacterial load. Respir Res 18(1):88
Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P (2005) Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 60(3):193–198
Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, Haldar K, Kebadze T, Duvoix A, Lindblad K (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 184(6):662–671
Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R (2014) Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J 44(6):1697–1700
Couillard S, Larivée P, Courteau J, Vanasse A (2017) Eosinophils in COPD exacerbations are associated with increased readmissions. Chest. 151(2):366–373
Oshagbemi OA, Franssen FM, Braeken DC, Henskens Y, Wouters EF, Maitland-van der Zee AH, Burden AM, de Vries F (2018) Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. Pharmacoepidemiol Drug Saf 27(11):1191–1199
Yun JH, Lamb A, Chase R, Singh D, Parker MM, Saferali A, Vestbo J, Tal-Singer R, Castaldi PJ, Silverman EK, Hersh CP (2018) Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 141(6):2037–2047
Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG (2016) Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population Study. Am J Respir Crit Care Med 193(9):965–974
Wedzicha JA (2016) Eosinophils as biomarkers of chronic obstructive pulmonary disease exacerbation risk. Maybe just for some? Am J Respir Crit Care Med 193:937–938
Bafadhel M, Peterson S, De Blas MA, Calverley PM, Rennard SI, Richter K, Fagerås M (2018) Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomized trials. Lancet Respir Med 6(2):117–126
Cai CS, Wang J (2019) Blood eosinophil level to predict chronic obstructive pulmonary disease clinical outcomes: not ready yet. Chin Med J (Engl) 132(19):2373
Wu HX, Zhuo KQ, Cheng DY (2019) Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 14:3003
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)
